Unibank offers USD-denominated coupon bonds with high yield of 4.8%

YEREVAN, December 2, / ARKA /. Unibank said today it has issued US dollar–denominated bonds with high annual coupon yield of 4.8% to the tune of $5 million and 36 month circulation term. According to the bank, coupon income will be paid quarterly.

The placement of the issue is expected to be completed by December 27, 2021, after which the bonds will be listed on the AMX Armenia Securities Exchange.

According to the Law of the Republic of Armenia On Guaranteeing the Compensation of Bank Deposits of Individuals,  funds attracted by the nominal bonds issued by a bank are considered as bank deposits guaranteed by the Deposit Guarantee Fund.

Income from bonds listed on the Armenian Securities Exchange with a maturity of two years or more is not taxable.

The prospectus of the bond program /registered on 22.01.2021, according to Decision 1/25A), its supplements, as well as the final terms of the issue are published on www.unibank.am. -0-

spot_img

POPULAR

“Unisport” Competes in the UEFA Futsal Champions League

Unisport Futsal Club, established with the sponsorship of Unibank, will host UEFA Futsal Champions League 2026/27 preliminary round matches in Yerevan on August 26, 27 and 29.

Armenian banks will provide citizens with account statements free of charge

Individuals in Armenia will be able to receive free electronic statements from commercial banks about their bank accounts, their balances, and the presence or absence of mutual obligations with the bank.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img